Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,212
Closed -$104K 32
2019
Q3
$104K Sell
9,212
-8,763,534
-100% -$101M 0.01% 28
2019
Q2
$109M Sell
8,772,746
-2,132,820
-20% -$26M 4.98% 11
2019
Q1
$136M Sell
10,905,566
-31,587
-0.3% -$430K 6.7% 4
2018
Q4
$156M Sell
10,937,153
-149,706
-1% -$2.17M 7.69% 1
2018
Q3
$165M Sell
11,086,859
-378,564
-3% -$5.18M 7.65% 1
2018
Q2
$152M Sell
11,465,423
-1,448,272
-11% -$19.5M 7.24% 1
2018
Q1
$177M Buy
12,913,695
+4,090,581
+46% +$58.4M 7.93% 3
2017
Q4
$138M Buy
8,823,114
+3,288,569
+59% +$48.4M 8.06% 2
2017
Q3
$77.6M Buy
+5,534,545
New +$90.9M 5.7% 5

Other funds holding KT

Antipodes Partners's KT Position: Q4 2019 in Review

Antipodes Partners sold out of KT (KT) in Q4 2019, closing a stake of 9,212 shares — an estimated $104K sold.

Antipodes Partners first reported a position in KT in Q3 2017 and held it in 9 quarters. The position peaked at $177M in Q1 2018. 143 funds tracked by Wall St. Rank hold KT as of Q4 2019.

  • Antipodes Partners reported no remaining KT position as of Q4 2019 after selling out during the quarter.
  • Antipodes Partners sold 9,212 KT shares in Q4 2019, an estimated $104K.
  • Antipodes Partners first reported a position in KT in Q3 2017 and held it in 9 quarters.
  • Antipodes Partners's KT position peaked at $177M in Q1 2018.
  • 143 funds tracked by Wall St. Rank held KT as of Q4 2019.

Based on Antipodes Partners's 13F filing for Q4 2019, filed 5 Feb 2020.